COVID-19: The Ivermectin African Enigma
Main Article Content
Introduction: The low frequency of cases and deaths from the SARS-CoV-2 COVID-19 virus in some countries of Africa has called our attention to the unusual behavior of this disease.
Aims: Describe SARS-CoV2 infection and death rates in African countries that participated in an intensive Ivermectin mass campaign carried out to control onchocerciasis and compare them with those of countries that did not participate.
Methods: Data from 19 countries that participated in the WHO sponsored African Programme for Onchocerciasis Control (APOC), from 1995 until 2015, intended to treat over 90 million people annually and protect an at-risk population of 115 million, were compared with thirty-five (Non-APOC), countries that were not included. Information was obtained from https://www.worldometers.info/coronavirus/ database.
Results After controlling for different factors including the Human Development Index, APOC countries, show statistically significant 28% lower mortality (0.72 IC 95% 0,67-0,78) and 8% lower rate of infection (0.92 IC95% 0,91-0,93) due to COVID-19.
Conclusions: The incidence in mortality rates and the number of cases is significantly lower among the APOC countries compared to non-APOC countries. That a mass public health preventive campaign against COVID-19 may have taken place, inadvertently, in some African countries with massive community ivermectin use is an attractive hypothesis. Additional studies are needed to confirm it.
- Luis Eduardo Bravo, Armando Cortés, Edwin Carrascal, Roberto Jaramillo, Luz Stella García, Paco Eduardo Bravo, Aníbal Badel, Pablo Andrés Bravo, Helicobacter pylori: patología y prevalencia en biopsias gástricas en Colombia. , Colombia Médica: Vol. 34 No. 3 (2003)
- Elvia Karina Grillo Ardila, Luis Eduardo Bravo Ocaña, Rodrigo Guerrero, Julián Santaella-Tenorio, Mathematical models and the coronavirus, COVID-19 , Colombia Médica: Vol. 51 No. 2 (2020): Coronavirus disease 2019
- Luis Eduardo Bravo Ocaña, Paola Collazos, Elvia Karina Grillo Ardila, Luz Stella García, Erquinovaldo Millán, Patricia Mera, Jorge Holguín, Mortality from respiratory infections and chronic non-communicable diseases before the COVID-19 pandemic in Cali, Colombia. , Colombia Médica: Vol. 51 No. 2 (2020): Coronavirus disease 2019
- Luis Eduardo Bravo, Nubia Muñoz, Epidemiology of cancer in Colombia , Colombia Médica: Vol. 49 No. 1 (2018): Colombia Cancer Epidemiology
- Luis Eduardo Bravo, Luz Stella García, Paola Collazos, Edwin Carrascal, Oscar Ramírez, Armando Cortés, Marcela Nuñez, Erquinovaldo Millán, Reliable information for cancer control in Cali, Colombia , Colombia Médica: Vol. 49 No. 1 (2018): Colombia Cancer Epidemiology
- Luz Stella Garcia, Luis Eduardo Bravo, Paola Collazos, Oscar Ramirez, Edwin Carrascal, Marcela Nuñez, Nelson Portilla, Erquinovaldo Millan, Cali Cancer Registry Methods , Colombia Médica: Vol. 49 No. 1 (2018): Colombia Cancer Epidemiology
- Armando Cortés, Lina María Isaza, Luis Eduardo Bravo, María Fernanda Palomino, Incidencia de seroconversión para infecciones virales trasmisibles por transfusión en donantes habituales de sangre en Cali. , Colombia Médica: Vol. 32 No. 4 (2001)
- Rodrigo Guerrero, Luis Eduardo Bravo, Edgar Muñoz, Elvia Karina Grillo Ardila, Esteban Guerrero, Reply to a letter from Robert Colebunders entitled COVID-19: The African Enigma , Colombia Médica: Vol. 52 No. 2 (2021): Damage Control Surgery (II)
- Luis Eduardo Bravo, Luz Stella Garcia, Paola Collazos, Edwin Carrascal, Elvia Karina Grillo-Ardila, Erquinovaldo Millan, Jorge Holguín, Cancer epidemiology in Cali, 60 years of experience , Colombia Médica: Vol. 53 No. 1 (2022): Cancer incidence and mortality
- Luis Eduardo Bravo, Luz Stella Garcia, Paola Collazos, Jorge Alirio Holguin, Isabelle Soerjomataram, Adalberto Miranda-Filho, Trends in long-term cancer survival in Cali, Colombia: 1998-2017 , Colombia Médica: Vol. 53 No. 1 (2022): Cancer incidence and mortality
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use